Overview
Craniopharyngioma is a rare, typically benign, slow-growing tumor arising near the pituitary gland, often affecting children and adolescents. It can lead to significant endocrine, visual, and cognitive impairments due to its location near critical brain structures 125.Diagnosis
Imaging: MRI is essential for diagnosis, delineating tumor characteristics and relationship to surrounding structures 13.
Immunohistochemistry: Useful for distinguishing subtypes; BRAF V600E mutation is more common in papillary types 1.
Clinical Presentation: Includes visual disturbances, hormonal deficiencies, and cognitive issues 5.
Grading: No standardized grading system universally accepted; clinical status scales like CCSS can assess functional outcomes 5.Management
Primary Surgery: Gross total resection or near-total resection when feasible; hypothalamus-sparing approaches aim to reduce obesity risk 4.
Adjuvant Therapy: Radiation or intracystic therapies (e.g., interferon) used post-surgery for residual or recurrent tumors 24.
Techniques: Endoscopic endonasal approaches effective for retrochiasmatic tumors, even with low-lying optic chiasm 3.
Special Techniques: Techniques for handling large, calcified fragments to achieve total removal 7.Special Populations
Pediatrics: Management controversial; hypothalamus-sparing surgery may reduce obesity risk without increasing recurrence 4.
Outcomes: High risk of disease progression; 5-year progression-free survival around 56.8%, overall survival near 92% 2.
Quality of Life: Focus on minimizing hypothalamic damage to preserve quality of life 4.Key Recommendations
Primary Surgery with Hypothalamus-Sparing Techniques: Consider hypothalamus-sparing approaches to minimize obesity risk in pediatric patients (Evidence: Moderate 4).
Adjuvant Radiation or Intracystic Therapy for Residual Disease: Use adjuvant treatments post-surgery for residual or recurrent tumors to improve progression-free survival (Evidence: Moderate 24).
Endoscopic Endonasal Approach for Retrochiasmatic Tumors: Utilize endoscopic endonasal techniques effectively even in cases with low-lying optic chiasm, without compromising clinical outcomes (Evidence: Moderate 3).References
1 Mukada N, Tosaka M, Matsumura N, Yamaguchi R, Aihara M, Isoda K et al.. Subtype-dependent difference of glucose transporter 1 and hexokinase II expression in craniopharyngioma: an immunohistochemical study. Scientific reports 2021. link
2 Liu AP, Tung JY, Ku DT, Luk CW, Ling AS, Kwong DL et al.. Outcome of Chinese children with craniopharyngioma: a 20-year population-based study by the Hong Kong Pediatric Hematology/Oncology Study Group. Child's nervous system : ChNS : official journal of the International Society for Pediatric Neurosurgery 2020. link
3 Kim KH, Kim YH, Dho YS, Kim JH, Hong SD, Choi JW et al.. Is Low-Lying Optic Chiasm an Obstacle to an Endoscopic Endonasal Approach for Retrochiasmatic Craniopharyngiomas? (Korean Society of Endoscopic Neurosurgery -003). World neurosurgery 2018. link
4 Müller HL. Paediatrics: surgical strategy and quality of life in craniopharyngioma. Nature reviews. Endocrinology 2013. link
5 Elliott RE, Sands SA, Strom RG, Wisoff JH. Craniopharyngioma Clinical Status Scale: a standardized metric of preoperative function and posttreatment outcome. Neurosurgical focus 2010. link
6 Ueyama Y, Kuratsuji T, Lee JY, Yamazaki T, Hata J, Tamaoki N. Congenital giant craniopharyngioma. Acta pathologica japonica 1985. link
7 Talalla A. Total removal of a craniopharyngioma. Technical note. Acta neurochirurgica 1975. link